Literature DB >> 22223916

Anaphylaxis with midazolam - Our experience.

Christina George1, Aparna Williams.   

Abstract

Entities:  

Year:  2011        PMID: 22223916      PMCID: PMC3249879          DOI: 10.4103/0019-5049.90633

Source DB:  PubMed          Journal:  Indian J Anaesth        ISSN: 0019-5049


× No keyword cloud information.
Sir, The overall incidence of anaphylaxis considering all agents used (local, general, regional) has been reported as 1 in 13,000 anesthetic procedures.[1] Midazolam hydrochloride is a short-acting imidazobenzodiazepine central nervous system (CNS) depressant commonly used for conscious sedation for a variety of procedures. Severe adverse reactions, including respiratory depression, laryngospasm,[2] respiratory arrest, tonic clonic seizures,[3] pruritis,[4] cardiac arrhythmias,[5] anaphylactic and anaphylactoid reactions have been described by manufacturers. We present a 26 year old, 53 kg, 165 cm tall male coming for cervical lymph node biopsy on an out patient basis. He had no previous drug or food allergies or atopy. He had undergone cervical lymph node biopsy under local anaesthesia supplemented with sedation (details unavailable) uneventfully. After institution of electrocardiogram (ECG), Oxygen saturation (SpO2), non-invasive blood pressure (NIBP) monitoring, an intravenous cannula was secured in the right forearm and lactated Ringer's solution infusion was started. Midazolam 1 mg was given intravenously to allay anxiety. Within 2 minutes of administration of intravenous Midazolam, the patient complained of pruritis over the right forearm and trunk, and urticarial wheals were noticed over these sites. The blood pressure decreased to 60/30 mm Hg and the heart rate decreased from 80 to 50/minute along with decrease in SpO2 to 85%. Patient was given 100% oxygen via face mask and injection Adrenaline 50 mcg was administered promptly. The intravenous fluids were rushed and the patient also received Chlorpheniramine 45 mg, Hydrocortisone 100 mg and Ranitidine 150 mg intravenously. Absent stridor or wheezing on auscultation ruled out airway involvement due to the drug reaction. Although the heart rate increased to 135/minute after injection of Adrenaline, no dysrrhythmias were observed. The blood pressure increased to 130/80 mm Hg, SpO2 increased to 100% and heart rate decreased to 116/minute within 15 minutes. The urticarial wheals disappeared and pruritis resolved 20 minutes after the injection of adrenaline. The surgical procedure was abandoned and the patient was monitored in the post-anaesthesia care unit (PACU) for any delayed response to the allergen. Blood samples were drawn for estimation of serum tryptase and sent to Ranbaxy laboratories. The patient underwent skin prick test 6 weeks later. The allergic reaction was documented in the patient's file. He was notified about the adverse reaction. The pathophysiology of anaphylaxis begins with binding of an allergen to Immunoglobulin E (IgE) on the surface of mast cells and basophils, with cross linking of receptors and subsequent cell activation. The resultant massive release of mediators such as histamine, leukotrienes, kinins, and eosinophil chemotactic factor leads to bronchoconstriction, vasodilatation, and increased capillary permeability. This process can continue, with progressive inflammation leading to a delayed “second wave” of symptoms six to eight hours later.[6] The anaphylactic reaction in our patient was due to Midazolam as he developed signs of anaphylaxis 2 minutes after receiving it. Ringer's lactate solution could not be implicated as the allergen as it had been checked for any precipitates prior to infusion and 300 ml of the solution had already been administered without any allergic signs and symptoms. He was not given any other medication prior to Midazolam. Beta-tryptase level tested by the mature tryptase immunoassay was 2 nanogram/milliliter and total-to-beta-tryptase ratio was 9, both suggesting severe anaphylaxis. Skin prick test was positive for Midazolam and negative for latex and other common drugs. Treatment of perioperative anaphylaxis includes removing the likely trigger, hydration and abandoning the procedure. One hundred percent oxygen should be applied. Epinephrine, the treatment of choice for anaphylaxis causes increased vasoconstriction, decreased mucosal edema, increased inotropy/chronotropy, and bronchodilation. Additionally, the β-agonist effect of epinephrine inhibits further mediator release from mast cells and basophils. H1 and H2 antagonists and corticosteroids blunt the recurrence of the reaction. Tryptase, a protease released from activated mast cells, can be used as a marker of immune activation. Serum beta –tryptase levels are raised in patients with systemic anaphylaxis. Total-to-beta tryptase ratio of 10 or less suggests systemic anaphylaxis.[7] This case describes an otherwise healthy man who experienced preoperative anaphylaxis most likely due to a widely used drug, Midazolam. Clinicians should remain cognizant of the risk of anaphylaxis as well as its treatment.
  6 in total

1.  Cardiac dysrhythmias with midazolam sedation.

Authors:  C R Rodrigo; J B Rosenquist; C H Cheng
Journal:  Anesth Prog       Date:  1990 Jan-Feb

2.  A reaction to midazolam: a topical solution.

Authors:  A Yates; D Russell
Journal:  Anaesthesia       Date:  1989-05       Impact factor: 6.955

3.  Development of a new, more sensitive immunoassay for human tryptase: use in systemic anaphylaxis.

Authors:  L B Schwartz; T R Bradford; C Rouse; A M Irani; G Rasp; J K Van der Zwan; P W Van der Linden
Journal:  J Clin Immunol       Date:  1994-05       Impact factor: 8.317

4.  [Epidemiology of anesthetic anaphylactoid reactions. Fourth multicenter survey (July 1994-December 1996)].

Authors:  M C Laxenaire
Journal:  Ann Fr Anesth Reanim       Date:  1999-08

Review 5.  Reversal of midazolam-induced laryngospasm with flumazenil.

Authors:  D P Davis; R S Hamilton; T H Webster
Journal:  Ann Emerg Med       Date:  1998-08       Impact factor: 5.721

6.  Epileptic fits under intravenous midazolam sedation.

Authors:  N D Robb
Journal:  Br Dent J       Date:  1996-09-07       Impact factor: 1.626

  6 in total
  3 in total

1.  Anaphylaxis with midazolam in pediatric hematology-oncology unit: a case report.

Authors:  Selma Çakmakcı; Turan Bayhan; Meriç Kaymak Cihan; İnci Ergürhan İlhan
Journal:  Turk Pediatri Ars       Date:  2018-09-01

2.  Drug-induced anaphylactic reactions in Indian population: A systematic review.

Authors:  Tejas K Patel; Parvati B Patel; Manish J Barvaliya; C B Tripathi
Journal:  Indian J Crit Care Med       Date:  2014-12

3.  A case of midazolam anaphylaxis.

Authors:  Jae Gyu Shin; Jong Ho Hwang; Ban Seok Lee; Hye Jung Park; Sang Ho Lee; Jae Nam Lee; Dong Hoon Han; Ji Ha Kim
Journal:  Clin Endosc       Date:  2014-05-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.